DOL OIG Audit The JOB CORPS.: Is it any wonder WHY President Trump stated he wanted ‘TO CUT THE BUDGET OF THE LABOR DEPT’, Specifically the JOB CORPS DEPT?!?

DOL OIG Audit The JOB CORPS.: Is it any wonder WHY President Trump stated he wanted ‘TO CUT THE BUDGET OF THE LABOR DEPT’, Specifically the JOB CORPS DEPT?!?

Semiannual Report to Congress, October 1, 2017 – March 31, 2018,

Office of Inspector General, Department of the Treasury

DOL OIG Audit The JOB CORPS.: Nevertheless, pharmaceutical prescriptions remain highly susceptible to fraud. Our current investigations are focusing on collusion between prescribing physicians and dispensing pharmacies

DOL OIG Audit The JOB CORPS.: Nevertheless, pharmaceutical prescriptions remain highly susceptible to fraud. Our current investigations are focusing on collusion between prescribing physicians and dispensing pharmacies

Semiannual Report to Congress, October 1, 2017 – March 31, 2018,

Office of Inspector General, Department of the Treasury

DOL OIG Audit The JOB CORPS.: WHAT IS BEING DONE ABOUT IT??? ➡The OIG has asked for increased congressional oversight, in November the Department began requiring letters of medical necessity for compounded medications it has since reported that expenditures for compounded drugs have significantly declined. The Investigation’s are still going on

DOL OIG Audit The JOB CORPS.: WHAT IS BEING DONE ABOUT IT???      ➡The OIG has asked for increased congressional oversight, in November the Department began requiring letters of medical necessity for compounded medications it has since reported that expenditures for compounded drugs have significantly declined.  The Investigation’s are still going on

Semiannual Report to Congress, October 1, 2017 – March 31, 2018,

Office of Inspector General, Department of the Treasury

DOL OIG Audit The JOB CORPS.: HOLY MOLY!! WHAT!?!? WHY? ➡This dramatic increase was due almost exclusively to the rise in reported costs for compounded drugs, which jumped from approximately $2 million in FY 2011 to $263 million in FY 2016, an increase of more than a hundredfold!!!

DOL OIG Audit The JOB CORPS.: HOLY MOLY!! WHAT!?!? WHY?      ➡This dramatic increase was due almost exclusively to the rise in reported costs for compounded drugs, which jumped from approximately $2 million in FY 2011 to $263 million in FY 2016, an increase of more than a hundredfold!!!

Semiannual Report to Congress, October 1, 2017 – March 31, 2018,

Office of Inspector General, Department of the Treasury

DOL OIG Audit The JOB CORPS.: The cost of prescription drugs in the Federal Employees’ Compensation Act (FECA) program rose from a reported $183 million in FY 2011 to $477 million in FY 2016, an increase of 161%.

DOL OIG Audit The JOB CORPS.: The cost of prescription drugs in the Federal Employees’ Compensation Act (FECA) program rose from a reported $183 million in FY 2011 to $477 million in FY 2016, an increase of 161%.

Semiannual Report to Congress, October 1, 2017 – March 31, 2018,

Office of Inspector General, Department of the Treasury